This website is for UK Healthcare Professionals.

Resources

The risk minimisation materials for Accord lenalidomide and thalidomide are available to download below

Materials available as editable pdfs:

exchange
Medicinal NameMaterialDescriptionDownload
LenalidomideHealthcare Professional’s PackContains the complete information needed by healthcare professionals for prescribing and dispensing Accord Lenalidomide, including information about the Pregnancy Prevention Programme (PPP). It is a requirement that healthcare professionals read and understand the PPP prior to prescribing and dispensing to any patient. The pack contains all educational risk minimisation materialsDownload PDF
ThalidomideHealthcare Professional’s PackContains the complete information needed by healthcare professionals for prescribing and dispensing Accord Thalidomide, including information about the Pregnancy Prevention Programme (PPP). It is a requirement that healthcare professionals read and understand the PPP prior to prescribing and dispensing to any patient. The pack contains all educational risk minimisation materialsDownload PDF
LenalidomidePharmacy Registration Form (PRF)Form for completion by the Chief Pharmacist, or their Appointed Deputy. Only pharmacies registered with Accord via the PRF can order and dispense Accord LenalidomideDownload PDF
ThalidomidePharmacy Registration Form (PRF)Form for completion by the Chief Pharmacist, or their Appointed Deputy. Only pharmacies registered with Accord via the PRF can order and dispense Accord ThalidomideDownload PDF
LenalidomidePrescription Authorisation Form (PAF)Form for completion by the prescriber and pharmacist. Each prescription of Accord Lenalidomide must be accompanied by a newly completed Prescription Authorisation Form (PAF)Download PDF
ThalidomidePrescription Authorisation Form (PAF)Form for completion by the prescriber and pharmacist. Each prescription of Accord Thalidomide must be accompanied by a newly completed Prescription Authorisation Form (PAF)Download PDF
LenalidomideMale Treatment Initiation Form (TIF)Form for completion by the prescriber for each male patient prior to the initiation of their Lenalidomide treatment. It is mandatory that all males receive counselling and education to be made aware of the risks with this medicineDownload PDF
ThalidomideMale Treatment Initiation Form (TIF)Form for completion by the prescriber for each male patient prior to the initiation of their Thalidomide treatment. It is mandatory that all males receive counselling and education to be made aware of the risks with this medicineDownload PDF
LenalidomideWomen of Childbearing Potential (WCBP) Treatment Initiation Form (TIF)Form for completion by the prescriber for each woman of childbearing potential prior to the initiation of their Lenalidomide treatment. It is mandatory that women of childbearing potential receive counselling and education to be made aware of the risks with this medicineDownload PDF
ThalidomideWomen of Childbearing Potential (WCBP) Treatment Initiation Form (TIF)Form for completion by the prescriber for each woman of childbearing potential prior to the initiation of their Thalidomide treatment. It is mandatory that women of childbearing potential receive counselling and education to be made aware of the risks with this medicineDownload PDF
LenalidomideWomen of Non-childbearing Potential (WNCBP) Treatment Initiation Form (TIF)Form for completion by the prescriber for each woman of non-childbearing potential prior to the initiation of their Lenalidomide treatment. It is mandatory that women of non-childbearing potential receive counselling and education to be made aware of the risks with this medicineDownload PDF
ThalidomideWomen of Non-childbearing Potential (WNCBP) Treatment Initiation Form (TIF)Form for completion by the prescriber for each woman of non-childbearing potential prior to the initiation of their Thalidomide treatment. It is mandatory that women of non-childbearing potential receive counselling and education to be made aware of the risks with this medicineDownload PDF
LenalidomideAdverse Event FormForm to facilitate the reporting of adverse events in relation to this medicine to AccordDownload PDF
ThalidomideAdverse Event FormForm to facilitate the reporting of adverse events in relation to this medicine to AccordDownload PDF
LenalidomidePregnancy FormForm to facilitate the immediate reporting to Accord of any suspected, or confirmed, pregnancy whilst a patient is receiving this treatmentDownload PDF
ThalidomidePregnancy FormForm to facilitate the immediate reporting to Accord of any suspected, or confirmed, pregnancy whilst a patient is receiving this treatmentDownload PDF
LenalidomidePregnancy Outcome FormForm to facilitate the report to Accord on the outcome of a pregnancy whilst a patient is receiving this treatmentDownload PDF
ThalidomidePregnancy Outcome FormForm to facilitate the report to Accord on the outcome of a pregnancy whilst a patient is receiving this treatmentDownload PDF

Materials available for download and print:

exchange
Medicinal NameMaterialDescriptionDownload
LenalidomideInformation for Healthcare ProfessionalsContains the information needed by healthcare professionals for prescribing and dispensing Accord Lenalidomide, including information about the Pregnancy Prevention Programme (PPP). It is a requirement that healthcare professionals read and understand the PPP prior to prescribing and dispensing to any patientDownload PDF
ThalidomideInformation for Healthcare ProfessionalsContains the information needed by healthcare professionals for prescribing and dispensing Accord Thalidomide, including information about the Pregnancy Prevention Programme (PPP). It is a requirement that healthcare professionals read and understand the PPP prior to prescribing and dispensing to any patientDownload PDF
LenalidomideTreatment Checklist and Algorithm
Checklist to assist the healthcare professional with counselling a patient before they commence lenalidomide treatment to ensure it is used safely and correctly. The Algorithm provides high level steps for the process of pharmacy registration and the dispensing of lenalidomideDownload PDF
ThalidomideTreatment Checklist and Algorithm
Checklist to assist the healthcare professional with counselling a patient before they commence thalidomide treatment to ensure it is used safely and correctly. The Algorithm provides high level steps for the process of pharmacy registration and the dispensing of thalidomideDownload PDF
LenalidomideInformation for Patients
Information to be given to each patient receiving treatment to provide important details about the Pregnancy Prevention Programme, including what the patient needs to be aware of before, during and after taking Accord Lenalidomide along with how to report any side effects.
Download PDF
ThalidomideInformation for Patients
Information to be given to each patient receiving treatment to provide important details about the Pregnancy Prevention Programme, including what the patient needs to be aware of before, during and after taking Accord Thalidomide along with how to report any side effects.
Download PDF
LenalidomidePatient Information CardCard to be given to each patient receiving treatment, as it provides important details about the Pregnancy Prevention Programme, including what the patient needs to be aware of before, during and after taking Accord Lenalidomide along with how to report any side effects.
Download PDF
ThalidomidePatient Information CardCard to be given to each patient receiving treatment, as it provides important details about the Pregnancy Prevention Programme, including what the patient needs to be aware of before, during and after taking Accord Thalidomide along with how to report any side effects.
Download PDF

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Accord-UK Ltd on 01271 385257 or email [email protected].

Please select

For UK Healthcare Professionals

If you are a UK healthcare professional and would like more information on lenalidomide or thalidomide from Accord, please click here

Report Adverse Events

Adverse events should be reported.
Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store.

Adverse events should also be reported to Accord-UK Ltd:

For the UK Public

For more information on lenalidomide or thalidomide from Accord, please click below .

Site intended for a UK audience only. UK-03777 April 2024